2008
Vaccine Protection by Live, Attenuated Simian Immunodeficiency Virus in the Absence of High-Titer Antibody Responses and High-Frequency Cellular Immune Responses Measurable in the Periphery
Mansfield K, Lang S, Gauduin M, Sanford H, Lifson J, Johnson R, Desrosiers R. Vaccine Protection by Live, Attenuated Simian Immunodeficiency Virus in the Absence of High-Titer Antibody Responses and High-Frequency Cellular Immune Responses Measurable in the Periphery. Journal Of Virology 2008, 82: 4135-4148. PMID: 18272584, PMCID: PMC2292994, DOI: 10.1128/jvi.00015-08.Peer-Reviewed Original ResearchMeSH KeywordsAnimalsAntibodies, ViralInterferon-gammaIntestinal MucosaLymphoid TissueMacaca mulattaNeutralization TestsRetroviridae ProteinsRNA, ViralSAIDS VaccinesSequence DeletionSimian Acquired Immunodeficiency SyndromeSimian immunodeficiency virusT-LymphocytesVaccines, AttenuatedViral Envelope ProteinsViral LoadViremiaConceptsAnti-SIV antibody responsesSimian immunodeficiency virusAntibody responseImmune responseVaccine protectionImmunodeficiency virusCopies/Gamma interferon enzyme-linked immunospotVaccine/challenge experimentsAttenuated simian immunodeficiency virusGut-associated lymphoid tissueHigh-titer antibody responsesAnti-SIV immune responsesEnzyme-linked immunospotMacrophage marker CD68Cellular immune responsesHumoral immune responseViral load measurementsWeeks of infectionNeutralization-resistant strainDouble-labeling experimentsVaccinated monkeysViral loadPeripheral bloodLymphoid tissue
2003
Importance of B-Cell Responses for Immunological Control of Variant Strains of Simian Immunodeficiency Virus
Johnson W, Lifson J, Lang S, Johnson R, Desrosiers R. Importance of B-Cell Responses for Immunological Control of Variant Strains of Simian Immunodeficiency Virus. Journal Of Virology 2003, 77: 375-381. PMID: 12477842, PMCID: PMC140644, DOI: 10.1128/jvi.77.1.375-381.2003.Peer-Reviewed Original ResearchConceptsHigh viral loadSimian immunodeficiency virusViral loadAntibody-mediated neutralizationImmunological controlEffective immunological controlImmunodeficiency virusVariant strainsContinuous viral replicationReplicative capacityB cell responsesGp120 envelope proteinTime of infectionHigh replicative capacityAntibody responseDisease progressionB cellsDay 14Tissue macrophagesExperimental infectionViral replicationRhesus monkeysVariable region 1InfectionV2 sequences